The abstract is read at the publisher; the summary is JClub's.
Adults with early-treated phenylketonuria show persistent brain metabolic differences versus healthy controls, including higher brain phenylalanine and N-acetylaspartate, with reduced myo-inositol, NAAG, and total creatine/phosphocreatine.
- Why it matters: Chronic cerebral phenylalanine exposure is known in PKU, but adult neurometabolic consequences and how metabolites track subacute phenylalanine fluctuations were unclear.
- What they did: Using 1H-MRS plus structural/functional MRI in 30 adults with early-treated PKU and 59 controls, investigators quantified predominantly white-matter metabolites and tested a randomized placebo-controlled crossover with four weeks of oral Phe loading.
- The result: Four weeks of oral Phe increased brain phenylalanine and reversibly decreased myo-inositol, while NAA, NAAG, and creatine compounds stayed unchanged; blood and brain Phe correlated strongly (r=0.83, p<0.001).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.